![Richard Peterson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Peterson
Directeur/Membre du Conseil chez
UNIVERSAL INSURANCE HOLDINGS, INC.
Fortune : 1 M $ au 31/05/2026
Profil
Richard D.
Peterson is currently an Independent Director at Universal Insurance Holdings, Inc. since 2014, a Member of The Financial Executives Institute, and Chief Financial Officer at Turn Biotechnologies, Inc. since 2022.
Formerly, Mr. Peterson was Director at The Arizona Center For Nature Conservation; Chief Financial Officer, Treasurer & Executive Vice President at Medicis Pharmaceutical Corp.
from 2011 to 2012; Senior Financial Auditor at PricewaterhouseCoopers LLP from 1992 to 1995; Chief Financial Officer at Clarus Therapeutics, Inc.; CFO & Principal Accounting Officer at NVN Liquidation, Inc. from 2015 to 2017; Chief Financial Officer at Botanix Pharmaceuticals Ltd. from 2019 to 2020; Chief Financial & Accounting Officer at Sienna Biopharmaceuticals, Inc. from 2017 to 2018; Chief Financial Officer at Dermavant Sciences, Inc. from 2018 to 2019; and Chief Financial Officer at Clarus Therapeutics Holdings, Inc. from 2021 to 2022.
Education includes an undergraduate degree from Arizona State University conferred in 1992.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/06/2026 | 28 869 ( 0,1 % ) | 1 M $ | 31/05/2026 |
Postes actifs de Richard Peterson
| Sociétés | Poste | Début |
|---|---|---|
| UNIVERSAL INSURANCE HOLDINGS, INC. | Directeur/Membre du Conseil | 05/06/2014 |
The Financial Executives Institute | Corporate Officer/Principal | 26/05/2009 |
Turn Biotechnologies, Inc.
 Turn Biotechnologies, Inc. Packaged SoftwareTechnology Services Develops proprietary ERA platform that enables to discover pharmaceutical therapeutics | Directeur Financier/CFO | 01/09/2022 |
Anciens postes connus de Richard Peterson
| Sociétés | Poste | Fin |
|---|---|---|
| CLARUS THERAPEUTICS HOLDINGS, INC. | Directeur Financier/CFO | 31/08/2022 |
| BOTANIX PHARMACEUTICALS LIMITED | Directeur Financier/CFO | 01/05/2020 |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Operates as a a biotechnology company focused on dermatology | Directeur Financier/CFO | 01/02/2019 |
| SIENNA BIOPHARMACEUTICALS, INC. | Directeur Financier/CFO | 29/03/2018 |
| NVN LIQUIDATION, INC. | Directeur Financier/CFO | 23/03/2017 |
Formation de Richard Peterson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Medicis Pharmaceutical Corp.
 Medicis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for dermatological usages | Health Technology |
Universal Insurance Holdings, Inc.
 Universal Insurance Holdings, Inc. Property/Casualty InsuranceFinance Operates as a holding company whose subsidiaries provides property and casualty insurance services | Finance |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Clarus Therapeutics, Inc.
 Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for men hypogonadism | Health Technology |
NVN Liquidation, Inc.
 NVN Liquidation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops treatment for nitric oxide’s immunomodulatory & anti microbial mechanisms | Health Technology |
Botanix Pharmaceuticals Ltd.
 Botanix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of dermatology and antimicrobial products | Health Technology |
Arizona State University
 Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Financial Executives Institute | |
The Arizona Center For Nature Conservation
 The Arizona Center For Nature Conservation Other Consumer ServicesConsumer Services Operates as a zoo that provides conservatory of animals and habitats | Consumer Services |
Sienna Biopharmaceuticals, Inc.
 Sienna Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and manufactures drugs for treating inflammatory skin disorders | Health Technology |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Operates as a a biotechnology company focused on dermatology | Health Technology |
Turn Biotechnologies, Inc.
Turn Biotechnologies, Inc. Packaged SoftwareTechnology Services Develops proprietary ERA platform that enables to discover pharmaceutical therapeutics | Technology Services |
Clarus Therapeutics Holdings, Inc.
 Clarus Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops oral T-replacement therapies | Health Technology |
